IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Akums Drugs and Pharmaceuticals IPO listing price is ₹ 796.35, issue price is [●], and currently trading at ₹ 571.40 as on May 30, 2025. Akums Drugs and Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Akums Drugs and Pharmaceuticals IPO is a Book Building listing on BSE,NSE exchange. The company is based in New Delhi and caters to Pharmaceutical sector. Ambit , Axis Bank , Citigroup Global Markets India , ICICI Securities are the merchant bankers of Akums Drugs and Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Akums Drugs and Pharmaceuticals IPO offer price is ₹ 679.00 and got listed at ₹ 796.35. Read Akums Drugs and Pharmaceuticals IPO details mentioned above.The IPO of Akums Drugs and Pharmaceuticals Limited was listed on 6th August 2024. As of today, Akums Drugs and Pharmaceuticals IPO is trading at ₹ 571.40, compared to the previous day’s close of ₹ 571.10. Read the report above for detailed IPO performance.
The issue price of Akums Drugs and Pharmaceuticals IPO was [●] per equity share.
Akums Drugs and Pharmaceuticals IPO was listed at ₹796.35 on the stock exchange on 6th August 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Akums Drugs and Pharmaceuticals IPO is ₹ 571.40.
The 52-week high for Akums Drugs and Pharmaceuticals IPO is ₹ 1175.90, while the 52-week low is ₹ 405.00. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Akums Drugs and Pharmaceuticals IPO listed at ₹ 796.35 against the issue price of [●] per equity share, showing a listing day gain/loss of 117.35 (17.28%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Akums Drugs and Pharmaceuticals IPO stock moved from its listing price of ₹ 796.35 to the current price of ₹571.40 per equity share, reflecting a change of -28.25% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Akums Drugs and Pharmaceuticals IPO issue date of May 30, 2025 and CMP of ₹571.40, the estimated CAGR is approximately -19.05%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
[●]
Listing Price :
₹ 796.35
Previous Day Closing
₹ 571.10
Akums Drugs and Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Akums Drugs and Pharmaceuticals Financial Review Page
Merchant Banker(s) of Akums Drugs and Pharmaceuticals IPO: Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited
Akums Drugs and Pharmaceuticals IPO subscription was 63.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Akums Drugs and Pharmaceuticals IPO listed at a listing price of 796.35 against the offer price of 679.00.
The current market price of Akums Drugs and Pharmaceuticals is 571.40.
Why Us?
